Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Complete Cervical Cancer Screening Solution Based on First-void Urine Self-sampling: Validation for Detection of Precursor Lesions

NCT04530201 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT04530201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Complete Cervical Cancer Screening Solution Based on First-void Urine Self-sampling: Validation for Detection of Precursor Lesions
Lead sponsor
Universiteit Antwerpen
Phase
Not applicable
Overall status
Completed
Start date
August 20, 2020
Completion date
February 28, 2022
Enrollment
332 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical intraepithelial neoplasia, hpv-related cervical carcinoma, human papilloma virus, urine